Issn Print: 1753-0393
Publication Date: 2017/10/01
Short‐term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9%
Author Information: Department of Endocrinology and Metabolism
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.